Cancers (Mar 2022)
Molecular Pathology of Pancreatic Cancer
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a biologically aggressive malignancy showing a remarkable resistance to existing therapies and is often diagnosed at an advanced stage, leaving only about 15–20% of patients with an option for surgical resection [...]
Keywords